Aminah A. Keats, ND, FABNO Ever since oophorectomy was first shown to cause regression of advanced breast cancer more than a century ago, deprivation of estrogenic signaling has been the […]
Daniel Lander, ND, FABNO and Katherine Neubauer, ND Aromatase inhibitors (AIs) have been shown to be more effective than tamoxifen alone in preventing breast cancer recurrence in postmenopausal [...]